Wilmington Pharma Tech Co. LLC

Integrated CRO/CMO founded in 2003 in Newark, Delaware (54-acre former DuPont/Merck campus). Offers small molecule API development and manufacturing from discovery to commercial scale, with HPAPI suites and regulatory support. Majority investment from Curewell Capital.